Table 1.
Study | Comparison assessment | Validity | Reliability |
Adams [46] | —a |
|
— |
Aghanavesi et al [48] | MDS-UPDRSc |
|
Interrater reliability:
|
Akram et al [38] | MDS-UPDRS |
|
— |
Albani et al [73] | MDS-UPDRS |
|
— |
Amano et al [69] | In-clinic assessment |
|
Interrater reliability:
|
Arora et al [70] | MDS-UPDRS |
|
— |
Arroyo-Gallego et al [49] | MDS-UPDRS |
|
— |
Bazgir et al [50] | MDS-UPDRS |
|
— |
Bochniewicz et al [82] | ARATf |
|
— |
Boroojerdi et al [37] | MDS-UPDRS |
|
— |
Burdea et al [71] | — | — | — |
Cabrera-Martos et al [67] | In-clinic assessment | — | Interrater reliability:
|
Cai et al [19] | MDS-UPDRS |
|
— |
Channa et al [20] | MDS-UPDRS |
|
— |
Cole et al [21] | MDS-UPDRS | — | — |
Creagh et al [59] | 9HPTh |
|
— |
Cunningham et al [74] | — | — | — |
Dai et al [22] | MDS-UPDRS |
|
Interrater agreement (Kendall W):
|
Dubuisson et al [91] | 9HPT |
|
— |
Ferreira et al [23] | MDS-UPDRS | — | — |
Giancardo et al [39] | MDS-UPDRS |
|
— |
Giuffrida et al [24] | MDS-UPDRS |
|
— |
Goetz et al [75] | MDS-UPDRS | — | — |
Halloran et al [25] | CAHAIi |
|
— |
Heijmans et al [26] | ESMk app (tremor questionnaire) |
|
— |
Hoffman et al [68] | In-clinic assessment |
|
Interrater reliability:
|
Hssayeni et al [27] | MDS-UPDRS |
|
— |
Iakovakis et al [52] | MDS-UPDRS |
|
— |
Iakovakis et al [51] | MDS-UPDRS |
|
— |
Jeon et al [28] | MDS-UPDRS |
|
— |
Jha et al [60] | MDS-UPDRS |
|
Interrater agreement:
|
Kim et al [29] | MDS-UPDRS |
|
Interrater reliability:
|
Kleinholdermann et al [85] | MDS-UPDRS |
|
— |
Kostikis et al [81] | MDS-UPDRS |
|
— |
Lam et al [41] | 9HPT |
|
Test–retest reliability:
|
Lee et al [53] | MDS-UPDRS |
|
— |
Lee et al [84] | FMAl |
|
— |
Lee et al [54] | MDS-UPDRS | — | — |
Lin et al [88] | — | — | — |
Lipsmeier et al [61] | MDS-UPDRS |
|
Test–retest reliability:
|
Londral et al [47] | — | — | Test–retest reliability:
|
Lopez-Blanco et al [76] | MDS-UPDRS |
|
Interrater reliability:
|
Mahadevan et al [30] | MDS-UPDRS |
|
Interrater reliability:
|
Matarazzo et al [42] | UPDRS-3 | — | — |
Memedi et al [77] | Visual assessment |
|
Test–retest reliability:
|
Mera et al [31] | — | — | — |
Mitsi et al [65] | MDS-UPDRS | — | — |
Noyce et al [43] | MDS-UPDRS |
|
— |
Orozco-Arroyave et al [62] | UPDRS-3 | — | — |
Pan et al [63] | MDS-UPDRS |
|
— |
Papadopoulos et al [40,55] | MDS-UPDRS | — | — |
Powers et al [78] | MDS-UPDRS |
|
— |
Pratap et al [66] | Longitudinal Neuro-QoLm scores |
|
— |
Prochazka and Kowalczewski [83] | ARAT and FMA |
|
Test–retest reliability:
|
Rigas et al [32] | MDS-UPDRS |
|
— |
Salarian et al [87] | MDS-UPDRS |
|
— |
San-Segundo et al [33] | — | — | — |
Sanchez-Perez et al [34] | MDS-UPDRS | — | — |
Schallert et al [56] | — | — | — |
Shribman et al [44] | 9HPT |
|
— |
Sigcha et al [79] | MDS-UPDRS |
|
— |
Simonet et al [57] | MDS-UPDRS |
|
— |
Stamatakis et al [35] | MDS-UPDRS |
|
— |
Tavares et al [86] | MDS-UPDRS |
|
— |
Trager et al [45] | MDS-UPDRS |
|
— |
Westin et al [80] | MDS-UPDRS |
|
Test–retest reliability:
|
Wissel et al [58] | MDS-UPDRS |
|
Test–retest reliability:
|
Wu et al [89] | MDS-UPDRS |
|
— |
Yu et al [72] | FMA |
|
— |
Zambrana et al [90] | — | — | — |
Zhan et al [64] | MDS-UPDRS |
|
— |
Zhang et al [36] | MDS-UPDRS |
|
— |
aData unavailable.
bAUC: area under the curve.
cMDS-UPDRS: Movement Disorder Society–Unified Parkinson’s Disease Rating Scale.
dICC: interclass coefficient.
eUPDRS: Unified Parkinson’s Disease Rating Scale.
fARAT: Action Research Arm Test.
gIADL: instrumental activities of daily living.
h9HPT: 9-hole peg test.
iCAHAI: Chedoke Arm and Hand Inventory.
jADL: activities of daily living.
kESM: experience sampling method.
lFMA: Fugl-Meyer Assessment.
mQoL: quality of life.